Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019

Am J Obstet Gynecol. 2020 Nov;223(5):768-770. doi: 10.1016/j.ajog.2020.08.001. Epub 2020 Aug 7.

Affiliations

¹ Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Stanford University, Stanford, CA. Electronic address: iiigbi@stanford.edu.
² Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Stanford University, Stanford, CA.
³ Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenosine Monophosphate / analogs & derivatives*
Adenosine Monophosphate / therapeutic use
Adult
Alanine / analogs & derivatives*
Alanine / therapeutic use
Antiviral Agents / therapeutic use*
COVID-19
Coronavirus Infections / drug therapy*
Female
Humans
Pandemics
Pneumonia, Viral / drug therapy*
Pregnancy
Pregnancy Complications, Infectious / drug therapy*
Treatment Outcome

Substances

Antiviral Agents
remdesivir
Adenosine Monophosphate
Alanine